# patients.

Yamada held discussions with his research staﬀ and quickly learned

that he was not alone in his opposition to the lawsuit. The team wanted

to be a part of the solution to global health issues, not party to a lawsuit

preventing such drugs from reaching those in dire need, but they felt

they lacked the power to change the company’s direction. Yamada felt